Australia-based Hysata, which is commercializing capillary-fed electrolysis technology developed at the University of Wollongong (earlier post) has closed its oversubscribed Series A funding round of $42.5 million AUD (US$30 million). Virescent Ventures led the funding round on behalf of the Clean Energy Finance Corporation (CEFC) (Aus), with participation from Kiko Ventures (UK), IP Group Australia, Vestas Ventures (Denmark), Hostplus (Aus) and BlueScope (via its ventures arm BlueScopeX TM) (Aus).